» Articles » PMID: 12941884

Identification of a Novel Cellular Transcriptional Repressor Interacting with the Latent Nuclear Antigen of Kaposi's Sarcoma-associated Herpesvirus

Overview
Journal J Virol
Date 2003 Aug 28
PMID 12941884
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The latent nuclear antigen (LNA) of Kaposi's sarcoma-associated herpesvirus (KSHV) has an essential role in viral latent infection. LNA maintains the stability of KSHV episomes and modulates the expression of cellular genes. A novel cellular protein KLIP1 was identified to interact with LNA through yeast two-hybrid screening, and confirmed by a glutathione S-transferase pull down assay. Domain mapping showed that KLIP1 interacted with the N-terminal domain of LNA. Northern blot hybridization with a KLIP1 probe identified a major transcript of 1.8 kb and a minor transcript of 2.8 kb. cDNA library screening and 5'-RACE revealed that the major transcript encoded an open-reading-frame of 1,257 bp and had a 5'-untranslated region of 73 nucleotides. The major KLIP1 transcript was ubiquitously present in different cell types examined. A KLIP1 synthetic peptide antibody detected a doublet of 58-kDa and 63-kDa proteins in a Western blot assay. KLIP1 had two putative nuclear localization signals and showed punctate nuclear localization when expressed as a GFP-fusion protein. KLIP1 interacted with LNA in vivo, as demonstrated by coimmunoprecipitation using KSHV-infected cells and colocalization when they were expressed as GFP- and DsRed-fusion proteins, respectively. Consistent with its interaction with LNA, nuclear localization, and possession of two leucine zipper motifs, KLIP1 behaved like a transcriptional factor and repressed herpes simplex virus thymidine kinase (TK) promoter activity in a mammalian one-hybrid assay. In addition, cotransfection with LNA alleviated the transcriptional repression effect of KLIP1 on TK promoter activity. These results suggest that KLIP1 is a new member of cellular transcriptional repressors, and that LNA is involved in deregulating cellular transcription process.

Citing Articles

A positive feedback loop of CENPU/E2F6/E2F1 facilitates proliferation and metastasis via ubiquitination of E2F6 in hepatocellular carcinoma.

Liu Y, Yao Y, Liao B, Zhang H, Yang Z, Xia P Int J Biol Sci. 2022; 18(10):4071-4087.

PMID: 35844791 PMC: 9274498. DOI: 10.7150/ijbs.69495.


Centromere protein U (CENPU) promotes gastric cancer cell proliferation and glycolysis by regulating high mobility group box 2 (HMGB2).

Deng T, Jiang X, He Z, Cai M, Chen C, Xu Z Bioengineered. 2021; 12(2):10194-10202.

PMID: 34872447 PMC: 8810026. DOI: 10.1080/21655979.2021.2002018.


Centromere protein U enhances the progression of bladder cancer by promoting mitochondrial ribosomal protein s28 expression.

Liu B, Ma T, Sun W, Gao W, Liu J, Li L Korean J Physiol Pharmacol. 2021; 25(2):119-129.

PMID: 33602882 PMC: 7893492. DOI: 10.4196/kjpp.2021.25.2.119.


CENP-50 is required for papilloma development in the two-stage skin carcinogenesis model.

Saito M, Kagawa N, Okumura K, Munakata H, Isogai E, Fukagawa T Cancer Sci. 2020; 111(8):2850-2860.

PMID: 32535988 PMC: 7419024. DOI: 10.1111/cas.14533.


MLF1IP promotes cells proliferation and apoptosis by regulating CyclinD1 in breast cancer.

Yang F, Wang Y, Dong S, Chen C, Huang D Int J Clin Exp Pathol. 2020; 10(12):11554-11562.

PMID: 31966511 PMC: 6966028.


References
1.
Ballestas M, Kaye K . Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA. J Virol. 2001; 75(7):3250-8. PMC: 114118. DOI: 10.1128/JVI.75.7.3250-3258.2001. View

2.
Ballestas M, Chatis P, Kaye K . Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science. 1999; 284(5414):641-4. DOI: 10.1126/science.284.5414.641. View

3.
Wang X, Zhang Y, Deng J, Pan H, Zhou F, Montalvo E . Characterization of the promoter region of the viral interferon regulatory factor encoded by Kaposi's sarcoma-associated herpesvirus. Oncogene. 2001; 20(4):523-30. DOI: 10.1038/sj.onc.1204115. View

4.
Moore P, Chang Y . Molecular virology of Kaposi's sarcoma-associated herpesvirus. Philos Trans R Soc Lond B Biol Sci. 2001; 356(1408):499-516. PMC: 1088441. DOI: 10.1098/rstb.2000.0777. View

5.
Boshoff C, Weiss R . Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus. Philos Trans R Soc Lond B Biol Sci. 2001; 356(1408):517-34. PMC: 1088442. DOI: 10.1098/rstb.2000.0778. View